Clinical trials have shown that these drugs lower mortality and reduce the risk of future cardiovascular events among people with CVD. However, in those without established CVD, the magnitude of effect is less clear end it is uncertain when the benefits of therapy outweigh the risks.Age itself is independently associated with the risk of CVD, and risk factors such as blood pressure, lipid disorder